PRAX Insider Trading Activity and SEC Form 4 Filings
PRAX insider trading summary
Over the past 12 months, insiders at Praxis Precision Medicines, Inc. (PRAX) reported 6 sales worth $7.5M by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $7.5M.
Latest PRAX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 20, 2025 | Alex Nemiroff | General Counsel and Secretary | Sell | $189K (977 @ $193.23) |
| Nov 20, 2025 | Alex Nemiroff | General Counsel and Secretary | Sell | $2.6M (13,339 @ $192.53) |
| Nov 20, 2025 | Alex Nemiroff | General Counsel and Secretary | Sell | $1.8M (9,100 @ $194.30) |
| Nov 20, 2025 | Lauren Mastrocola | Principal Accounting Officer | Sell | $413K (2,145 @ $192.71) |
| Nov 20, 2025 | Alex Nemiroff | General Counsel and Secretary | Sell | $327K (1,714 @ $190.86) |
| Nov 20, 2025 | Lauren Mastrocola | Principal Accounting Officer | Sell | $2.2M (11,455 @ $191.96) |
| Oct 16, 2025 | Adage Capital Management, L.P. | 10% Owner | Sell | $1.1M (12,600 @ $90.00) |
| Oct 16, 2025 | Phillip Gross | 10% Owner | Sell | $1.1M (12,600 @ $90.00) |
| Oct 16, 2025 | Phillip Gross | 10% Owner | Sell | $125K (1,363 @ $92.03) |
| Oct 16, 2025 | Robert Atchinson | 10% Owner | Sell | $41K (447 @ $91.04) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.